Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 11, 2022.
Line Uhrenholt, MD, discusses the results of her randomized, open-label, equivalence trial study evaluating disease activity-guided tapering of biologics in patients with inflammatory arthritis.
Karin Schenck-Gustafsson, MD, PhD, FESC, explains why sex and gender must be taken into account when treating and managing patients with rheumatic disease from a cardiologist's perspective.
Investigators believe that treatment escalation within patients with rheumatoid arthritis should utilize interventions beyond the traditional physician-patient relationship.
Findings suggested that actigraphy may provide additional information to self-reported sleep measures in patients with rheumatoid arthritis.
A personal history rather than a family history of psoriasis is associated with the disease activity and severity of axial joint damage.